201 related articles for article (PubMed ID: 17313363)
1. Mast cell tryptase beta as a target in allergic inflammation: an evolving story.
Sommerhoff CP; Schaschke N
Curr Pharm Des; 2007; 13(3):313-32. PubMed ID: 17313363
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of tryptase for the treatment of mast cell-mediated diseases.
Rice KD; Tanaka RD; Katz BA; Numerof RP; Moore WR
Curr Pharm Des; 1998 Oct; 4(5):381-96. PubMed ID: 10197050
[TBL] [Abstract][Full Text] [Related]
3. Heparin antagonists are potent inhibitors of mast cell tryptase.
Hallgren J; Estrada S; Karlson U; Alving K; Pejler G
Biochemistry; 2001 Jun; 40(24):7342-9. PubMed ID: 11401583
[TBL] [Abstract][Full Text] [Related]
4. Active monomers of human beta-tryptase have expanded substrate specificities.
Fukuoka Y; Schwartz LB
Int Immunopharmacol; 2007 Dec; 7(14):1900-8. PubMed ID: 18039527
[TBL] [Abstract][Full Text] [Related]
5. The human mast cell tryptase tetramer: a fascinating riddle solved by structure.
Sommerhoff CP; Bode W; Matschiner G; Bergner A; Fritz H
Biochim Biophys Acta; 2000 Mar; 1477(1-2):75-89. PubMed ID: 10708850
[TBL] [Abstract][Full Text] [Related]
6. Tryptase inhibitors: a patent review.
Ni WW; Cao MD; Huang W; Meng L; Wei JF
Expert Opin Ther Pat; 2017 Aug; 27(8):919-928. PubMed ID: 28425830
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of mast cell tryptase beta as therapeutics for the treatment of asthma and inflammatory disorders.
Cairns JA
Pulm Pharmacol Ther; 2005; 18(1):55-66. PubMed ID: 15607128
[TBL] [Abstract][Full Text] [Related]
8. Mast cell tryptases and airway remodeling.
Sommerhoff CP
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S52-8. PubMed ID: 11734467
[TBL] [Abstract][Full Text] [Related]
9. Dual functionality of β-tryptase protomers as both proteases and cofactors in the active tetramer.
Maun HR; Liu PS; Franke Y; Eigenbrot C; Forrest WF; Schwartz LB; Lazarus RA
J Biol Chem; 2018 Jun; 293(25):9614-9628. PubMed ID: 29661938
[TBL] [Abstract][Full Text] [Related]
10. Polycationic peptides as inhibitors of mast cell serine proteases.
Lundequist A; Juliano MA; Juliano L; Pejler G
Biochem Pharmacol; 2003 Apr; 65(7):1171-80. PubMed ID: 12663052
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human mast cell tryptase by benzamidine derivatives.
Stürzebecher J; Prasa D; Sommerhoff CP
Biol Chem Hoppe Seyler; 1992 Oct; 373(10):1025-30. PubMed ID: 1418674
[TBL] [Abstract][Full Text] [Related]
12. Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases.
Caughey GH; Raymond WW; Bacci E; Lombardy RJ; Tidwell RR
J Pharmacol Exp Ther; 1993 Feb; 264(2):676-82. PubMed ID: 8437115
[TBL] [Abstract][Full Text] [Related]
13. Bivalent inhibition of human beta-tryptase.
Schaschke N; Matschiner G; Zettl F; Marquardt U; Bergner A; Bode W; Sommerhoff CP; Moroder L
Chem Biol; 2001 Apr; 8(4):313-27. PubMed ID: 11325588
[TBL] [Abstract][Full Text] [Related]
14. Tryptase inhibition blocks airway inflammation in a mouse asthma model.
Oh SW; Pae CI; Lee DK; Jones F; Chiang GK; Kim HO; Moon SH; Cao B; Ogbu C; Jeong KW; Kozu G; Nakanishi H; Kahn M; Chi EY; Henderson WR
J Immunol; 2002 Feb; 168(4):1992-2000. PubMed ID: 11823536
[TBL] [Abstract][Full Text] [Related]
15. Human beta-tryptase is a ring-like tetramer with active sites facing a central pore.
Pereira PJ; Bergner A; Macedo-Ribeiro S; Huber R; Matschiner G; Fritz H; Sommerhoff CP; Bode W
Nature; 1998 Mar; 392(6673):306-11. PubMed ID: 9521329
[TBL] [Abstract][Full Text] [Related]
16. Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone.
Costanzo MJ; Yabut SC; Almond HR; Andrade-Gordon P; Corcoran TW; De Garavilla L; Kauffman JA; Abraham WM; Recacha R; Chattopadhyay D; Maryanoff BE
J Med Chem; 2003 Aug; 46(18):3865-76. PubMed ID: 12930148
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug.
Erba F; Fiorucci L; Pascarella S; Menegatti E; Ascenzi P; Ascoli F
Biochem Pharmacol; 2001 Feb; 61(3):271-6. PubMed ID: 11172730
[TBL] [Abstract][Full Text] [Related]
18. Histidines are critical for heparin-dependent activation of mast cell tryptase.
Hallgren J; Bäckström S; Estrada S; Thuveson M; Pejler G
J Immunol; 2004 Aug; 173(3):1868-75. PubMed ID: 15265919
[TBL] [Abstract][Full Text] [Related]
19. Mast cell tryptase - Marker and maker of cardiovascular diseases.
Mohajeri M; Kovanen PT; Bianconi V; Pirro M; Cicero AFG; Sahebkar A
Pharmacol Ther; 2019 Jul; 199():91-110. PubMed ID: 30877022
[TBL] [Abstract][Full Text] [Related]
20. A fluorescent light-up probe as an inhibitor of intracellular β-tryptase.
Wang Q; Shi X; Zhu X; Ehlers M; Wu J; Schmuck C
Chem Commun (Camb); 2014 Jun; 50(46):6120-2. PubMed ID: 24776645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
